Jan 8, 2026 03:40AM
Dec 15, 2025 04:05PM
Dec 15, 2025 04:05PM
Nov 26, 2025 10:46AM
Nov 20, 2025 08:30AM
Nov 19, 2025 08:55AM
Nov 14, 2025 08:05AM IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Nov 12, 2025 08:30AM
Nov 7, 2025 09:02AM
Nov 7, 2025 09:00AM
Oct 20, 2025 02:30AM
Oct 20, 2025 02:30AM
Sep 29, 2025 04:40PM
Sep 29, 2025 11:54AM H.C. Wainwright Downgrades IO Biotech (IOBT) to Neutral
Sep 29, 2025 07:06AM
Sep 29, 2025 07:05AM
Sep 23, 2025 08:11AM
Sep 23, 2025 08:05AM
Sep 4, 2025 08:05AM
Aug 14, 2025 04:05PM
Aug 11, 2025 04:26PM IO Biotech (IOBT) PT Lowered to $4 at Morgan Stanley
Aug 11, 2025 08:01AM
Aug 11, 2025 08:00AM
May 14, 2025 08:05AM
Mar 4, 2025 04:18PM
Mar 4, 2025 04:17PM
Feb 23, 2025 12:07PM
Feb 4, 2025 08:05AM IO Biotech (IOBT) Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112
Feb 4, 2025 08:05AM
Nov 12, 2024 07:05AM
May 14, 2024 07:55AM
Aug 11, 2023 08:05AM
Aug 11, 2023 08:05AM
May 11, 2023 04:05PM
Nov 3, 2022 08:03AM IO Biotech (IOBT) Announces New Clinical Collaboration with Merck (MRK) to Evaluate Neoadjuvant and Adjuvant IO102-IO103 in Combination With KEYTRUDA in Phase 2, Multi-cohort Trial in Patients with Re
Nov 3, 2022 08:00AM
Oct 13, 2022 04:06PM
Oct 13, 2022 04:05PM
Oct 5, 2022 08:05AM
May 18, 2022 07:00AM
Apr 22, 2022 08:33AM
Apr 12, 2022 08:30AM IO Biotech Announces Initiation of Phase 2 Trial of IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Multi-Arm Basket Trial
Dec 9, 2021 11:05AM
Dec 9, 2021 11:05AM
Dec 6, 2021 08:04AM
Dec 6, 2021 08:00AM
Oct 18, 2021 05:47AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All